Erector Spinae Block in First Rib Resection: a Monocentric Before-after Study
NCT ID: NCT04167046
Last Updated: 2019-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2019-11-30
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In our center, first rib resection surgery was usually performed under general anesthesia combined with diffuse local infiltration of the axillary fossa. Erector spinae block is an interfascial block where a local anesthetic is injected between the erector spinae muscle and the transverse process, in order to obtain a multimetameric analgesia. It has now shown its efficacy and its safety in thoracic and abdominal surgeries by decreasing the morphine consumption and pain scores. Since November 2018, this erector spinae block is systematically performed preoperatively for first rib resection in our center, in association with a general anesthesia. Patient satisfaction seems important but remains to be assessed objectively.
In a before-after study, our goal is to assess the impact of the use of erector spinae block on postoperative pain in the first rib resection surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Erector Spinae Block, Epidural Analgesia and Intrathecal Analgesia in Thoracic Surgery
NCT04147754
Analgesic Effect of Erector Spinae Versus Serratus Anterior Plane Block for Thoracoscopic Sympathectomy
NCT04486014
Rib Microtia and the Erector Spinae Plane (ESP) Block
NCT03729427
Rhomboid Intercostal Block vs Erector Spina Plan Block for Peri-operative Analgesia in Mastectomy
NCT04259502
To Compare the Analgesic Effects of Different Nerve Block Analgesia Methods in Thoracoscopic Surgery
NCT06598852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Patients in this group did not receive an erector spinae block. Data are obtained retrospectively (years 2017 and 2018).
No interventions assigned to this group
Erector spinae block
Patients in this group receive an erector spinae block. Data will be obtained prospectively.
Erector spinae block
Preoperative erector spinae block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector spinae block
Preoperative erector spinae block.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel Rineau, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Angers, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Département d'Anesthésie-Réanimation du CHU d'Angers
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Siaudeau Hélène, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emmanuel Rineau, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019/98
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.